HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Permissions Request Permissions Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Schwarz, C. Articles by Loddenkemper, R. Search for Related Content PubMed PubMed Citation Articles by Schwarz, C. Articles by Loddenkemper, R.

Medical thoracoscopy: hormone receptor content in pleural metastases due to breast cancer

¹ Dept of Pneumology II, Lungenklinik Heckeshorn/Zentralklinik Emil von Behring, ² Institute of Pathology/Zentralklinik Emil von Behring, and ³ Dept of Gynaecological Endocrinology, Infertility and Family Planning, University Hospital Benjamin Franklin, JointFacility of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

CORRESPONDENCE: R. Loddenkemper, Lungenklinik Heckeshorn, Zum Heckeshorn 33, Berlin, Germany. Fax: 49 302618980. E-mail: r.loddheck@zedat.fu-berlin.de

Keywords: Breast cancer, malignant pleural effusion, medical thoracoscopy, oestrogen and progesterone receptors

Received: October 13, 2003
Accepted January 21, 2004

Pleural metastases are common in the course of breast cancer, but, to date, the role of oestrogen receptor (OR) and progesterone receptor (PgR) content in metastatic tissue has been poorly evaluated.

A series of 50 consecutive patients with a history of breast cancer (median age 64 yrs, range 40–86 yrs), which presented with pleural effusion and therefore underwent medical thoracoscopy, was analysed. Metastatic pleural involvement was histologically confirmed in all patients. The hormone receptor status of the pleural metastases was investigated using the immunohistochemical method in 49 and the biochemical method in 31 cases. The immunohistochemical test was performed using monoclonal antibodies. Biochemical analysis was performed on specimens quick-frozen in liquid nitrogen. OR and PgR were measured with the dextran-coated charcoal assay and Scatchard analysis.

Immunohistochemical analysis yielded 29 OR-positive and 25 PgR-positive cases and biochemical analysis yielded 16 OR-positive and four PgR-positive cases, sometimes discrepant to hormone status of the primary breast cancer. Using a semiquantitative immunoreactive score, there was a significant association between receptor positivity and survival, but only for PgR positivity.

Immunohistochemical and biochemical detection of hormone receptors (oestrogen and progesterone) in pleural metastases of breast cancer is feasible based on medical thoracoscopy as the method of choice, by which sufficient specimens may be obtained. The receptor status may enable a decision on antihormonal treatment. Whether a positive receptor status in pleural metastatic tissue is associated with a better prognosis remains to be confirmed.